Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?

Arab Journal of Gastroenterology

Volumn 16, Issue 2, 2015, Pages 54-58

  Almobarak, Ahmed O ^a   Barakat, Salma ^b   Suliman, Eltayeb A ^b   Elmadhoun, Wadie M ^c   Mohamed, Nabeel A ^d   Abobaker, Israa O ^e   Noor, Sufian K ^c   Bushara, Sarra O ^c   Ahmed, Mohamed H ^f  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b FEDERAL MINISTRY OF HEALTH   (Sudan)

^c NILE VALLEY UNIVERSITY   (Sudan)

^d Sentara Obici Hospital   (United States)

^e UNIVERSITY OF KHARTOUM   (Sudan)

^f MILTON KEYNES UNIVERSITY HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Fatty liver; Metabolic syndrome; Obesity; Sudan; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL; LIPID;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE DURATION; FEMALE; HUMAN; HYPERTENSION; INSULIN TREATMENT; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; SUDAN; TRIACYLGLYCEROL BLOOD LEVEL; AGED; BLOOD; BODY MASS; COMORBIDITY; COMPLICATION; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; WAIST CIRCUMFERENCE;

ADULT; AGE DISTRIBUTION; AGED; BODY MASS INDEX; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PREVALENCE; SUDAN; WAIST CIRCUMFERENCE;

EID: 84938971499     PISSN: 16871979     EISSN: 20902387     Source Type: Journal    
DOI: 10.1016/j.ajg.2015.06.001     Document Type: Article

References (34)

1. Ahmed M.H., Barakat S., Almobarak A.O. Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists?. J Obes 2012, 2012:483135.
2. Hamad A.A., Khalil A.A., Connolly V., Ahmed M.H. Relationship between non-alcoholic fatty liver disease and kidney function: a communication between two organs that needs further exploration. Arab J Gastroenterol 2012, 13:161-165.
3. Adams L.A., Harmsen S., St Sauver J.L., et al. Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. Am J Gastroenterol 2010, 105(7):1567-1573.
4. Kim H.J., Kim H.J., Lee K.E., et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 2004, 164:2169-2175.
5. Bedogni G., Miglioli L., Masutti F., Tiribelli C., Marchesini G., Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005, 42:44-52.
6. Bellentani S., Saccoccio G., Masutti F., et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000, 132:112-117.
7. Rocha R., Cotrim H.P., Carvalho F.M., Siqueira A.C., Braga H., Freitas L.A. Body mass index and waist circumference in non-alcoholic fatty liver disease. J Hum Nutr Diet 2005, 18:365-370.
8. el-Hassan A.Y., Ibrahim E.M., al-Mulhim F.A., Nabhan A.A., Chammas M.Y. Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management. Br J Radiol 1992, 65:774-778.
9. Akbar D.H., Kawther A.H. Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic: prevalence and general characteristics. Diabetes Care 2003, 26:3351-3352.
10. Williamson R.M., Price J.F., Glancy S., et al. Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 2011, 34:1139-1144.
11. Targher G., Bertolini L., Padovani R., et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007, 30:1212-1218.
12. Chan W.K., Tan A.T., Vethakkan S.R., Tah P.C., Vijayananthan A., Goh K.L. Non-alcoholic fatty liver disease in diabetics - prevalence and predictive factors in a multiracial hospital clinic population in Malaysia. J Gastroenterol Hepatol 2013, 28:1375-1383.
13. Lv W.S., Sun R.X., Gao Y.Y., et al. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes. World J Gastroenterol 2013, 19:3134-3142.
14. Ferreira V.S., Pernambuco R.B., Lopes E.P., et al. Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. Arq Bras Endocrinol Metabol 2010, 54:362-368.
15. Almobarak A.O., Barakat S., Khalifa M.H., Elhoweris M.H., Elhassan T.M., Ahmed M.H. Non alcoholic fatty liver disease (NAFLD) in Sudanese population: what is the prevalence and risk factors?. Arab J Gastroenterol 2014, 15(1):12-15.
16. Chitturi S., Abeygunasekera S., Farrell G.C., et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002, 35:373-379.
17. Ahmed M.H., Byrne C.D. Non alcoholic steatohepatitis and metabolic syndrome. Metabolic syndrome 2005, 279-305. John Wiley & Sons, Chichester, UK. C. Byrne, S. Wild (Eds.).
18. Ahmed M.H., Byrne C.D. Metabolic syndrome, diabetes & CHD risk. The year in lipid disorders 2007, 3-26. Clinical Publishing, Oxford UK. C.J. Packard (Ed.).
19. Pagano G., Pacini G., Musso G., et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002, 35:367-372.
20. Wang T.D., Goto S., Bhatt D.L., Steg P.G., Chan J.C., Richard A.J., et al. REACH Registry Investigators. Ethnic differences in the relationships of anthropometric measures to metabolic risk factors in Asian patients at risk of atherothrombosis: results from the REduction of Atherothrombosis for Continued Health (REACH) Registry. Metabolism 2010, 59(3):400-408.
21. Carbone F., Montecucco F., Mach F., Pontremoli R., Viazzi F. The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome. Thromb Haemost 2013, 110(5):940-958.
22. Chalasani N., Younossi Z., Lavine J.E., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012, 55:2005-2023.
23. Fierbinteanu-Braticevici C., Dina I., Petrisor A., Tribus L., Negreanu L., Carstoiu C. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. World J Gastroenterol 2010, 16:4784-4791.
24. Zhou J., Jia W.P., Bao Y.Q., et al. Study on prevalence and risk factors of fatty liver of patients with type 2 diabetes. Zhonghua Yi Xue Za Zhi 2007, 87:2249-2252.
25. Lu H., Zeng L., Liang B., Shu X., Xie D. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease. Arch Med Res 2009, 40:571-575.
26. Duvnjak M., Lerotic I., Barsic N., Tomasic V., Virovic J.L., Velagic V. Pathogenesis and management issues for non-alcoholic fatty liver disease. World J Gastroenterol 2007, 13:4539-4550.
27. Meshkani R., Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem 2009, 42:1331-1346.
28. Tsuneto A., Hida A., Sera N., et al. Fatty liver incidence and predictive variables. Hypertens Res 2010, 33:638-643.
29. Lee J.Y., Kim K.M., Lee S.G., et al. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 2007, 47:239-244.
30. Assy N., Kaita K., Mymin D., Levy C., Rosser B., Minuk G. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci 2000, 45:1929-1934.
31. Byrne C.D., Olufadi R., Bruce K.D., Cagampang F.R., Ahmed M.H. Metabolic disturbances in non-alcoholic fatty liver disease. Clin Sci (Lond) 2009, 116:539-564.
32. Eguchi Y., Eguchi T., Mizuta T., et al. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J Gastroenterol 2006, 41:462-469.
33. Marceau P., Biron S., Hould F.S., et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999, 84:1513-1517.
34. Hanley A.J., Williams K., Festa A., Wagenknecht L.E., D'Agostino R.B., Haffner S.M. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes 2005, 54:3140-3147.